Related Experiment Video
Updated: May 15, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
SOCS and diabetes--ups and downs of a turbulent relationship
Dariusz Suchy1, Krzysztof Łabuzek, Grzegorz Machnik
1Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. dariuszsuchy@gmail.com
Abstract:
Diabetes mellitus is one of the most emerging diseases threatening the present world. Thus, intensive investigations are carried out to better understand the mechanisms occurring in type 1 (T1D) and 2 (T2D) diabetes, and to elaborate more potent methods to fight the disease. In this aspect, the suppressors of cytokine signalling (SOCS) are one of the most studied factors of recent years. SOCS proteins have been discovered as cytokine pathway inhibitors; however, presently, their influence seems wider. Most of the known SOCS proteins are involved in the modulation of the development of insulin resistance, β-cell failure and eventually T1D and T2D. They are also involved in complications related with diabetes, such as retinopathy, nephropathy and cardiomyopathy. In T1D, SOCS proteins regulate β-cell mass, mediate resistance to damaging factors and improve pancreatic islet graft survival. Regarding insulin resistance and T2D, SOCS proteins take part in mediating signals produced by diabetogenic substances and regulate insulin receptor functioning, affecting insulin sensitivity. However, not all of the present data are consistent, and thus, further studies are required. Finally, for several pharmacologically active substances of importance regarding the treatment of diabetes, SOCS-modulating properties have already been described. Here, we review the findings of SOCS-diabetes relations of the last decade.
Insights
Suppressors of cytokine signalling (SOCS) proteins influence insulin resistance and diabetes development. Research highlights their role in type 1 and type 2 diabetes and related complications, suggesting therapeutic potential.
Area of Science:
- Endocrinology
- Immunology
- Molecular Biology
Background:
- Diabetes mellitus (T1D and T2D) poses a global health threat, necessitating deeper mechanistic understanding and improved treatments.
- Suppressors of cytokine signalling (SOCS) proteins, initially identified as cytokine pathway inhibitors, exhibit broader roles.
- SOCS proteins are increasingly recognized for their involvement in metabolic regulation and immune responses relevant to diabetes.
Purpose of the Study:
- To review the multifaceted roles of SOCS proteins in the pathogenesis of type 1 and type 2 diabetes.
- To explore the involvement of SOCS proteins in diabetes-related complications.
- To summarize recent findings on the therapeutic potential of modulating SOCS proteins for diabetes treatment.
Main Methods:
- Literature review of studies published in the last decade.
- Analysis of research on SOCS protein function in models of T1D and T2D.
- Examination of data linking SOCS proteins to insulin resistance, beta-cell function, and diabetes complications.
Main Results:
- SOCS proteins modulate beta-cell mass and survival in T1D, enhancing graft survival.
- In T2D and insulin resistance, SOCS proteins mediate signals from diabetogenic substances and regulate insulin receptor function.
- SOCS proteins are implicated in diabetes complications, including retinopathy, nephropathy, and cardiomyopathy.
Conclusions:
- SOCS proteins are critical regulators in both T1D and T2D pathogenesis and progression.
- Modulating SOCS proteins presents a potential therapeutic strategy for diabetes and its complications.
- Further research is warranted to reconcile inconsistent findings and fully elucidate SOCS-diabetes interactions.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes I: Introduction
Diabetes Mellitus: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
